(SLE)
BENUFUTAMAB(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[HOMO SAPIENS TNFRSF10B (TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 10B, DEATH RECEPTOR 5, DR5, TNFRELATED APOPTOSIS-INDUCING LIGAND RECEPTOR 2, TRAILR2, TR-2, CD262)], MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN CHIMERIC (1-447) [VH (MUS MUSCULUS IGHV14-3*02 G63>T (56) (87.8%) -(IGHD) - IGHJ2*01 (86.7%)/HOMO SAPIENSIGHV1-3*01 G63>T (56) (71.4%) -(IGHD) -IGHJ4*01 (100%)) [8.8.11] (1- 118) -HOMO SAPIENS IGHG1*03,G1M3, NG1M1 (CH1 R120 (215) (119-216), HINGE 1-15 (217-231), CH2 (232-341), CH3 E12 (357), M14 (359), E109>G (431) (342-446), CHS K2>DEL (447)) (119-447)], (221-214')- DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-214') [VKAPPA (HOMO SAPIENS IGKV3-15*01 (89.5%) - IGKJ2*01 (100%)) [6.3.9] (1'-107') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'- 214')]; DIMER (227-227'':230-230'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO)-DG44 CELL LINE, GLYCOFORM ALFA. PROPOSED INN LIST 121(WHOM)
BENUFUTAMABUM(INN)